Test your knowledge on the use of bone-modifying agents in patients with prostate cancer

When does the risk of bone fracture begin during treatment with androgen-deprivation therapy?
2 months
4 months
6 months
Which of the following is NOT a potential adverse event in patients receiving zoledronic acid or denosumab?
Osteonecrosis of the jaw
Hypocalcemia
Seizures
Why is the duration of BMAs in treating castration-resistant prostate cancer a crucial discussion point?
Older patients are living longer
 Serious adverse events
Negative impact on androgen-deprivation therapy
0
{"name":"Test your knowledge on the use of bone-modifying agents in patients with prostate cancer", "url":"https://www.quiz-maker.com/QMH0TFMBI","txt":"When does the risk of bone fracture begin during treatment with androgen-deprivation therapy?, Which of the following is NOT a potential adverse event in patients receiving zoledronic acid or denosumab?, Why is the duration of BMAs in treating castration-resistant prostate cancer a crucial discussion point?","img":"https://www.quiz-maker.com/3012/images/ogquiz.png"}